Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Jerash Holdings (US) (JRSH) EBITDA: 2016-2025

Historic EBITDA for Jerash Holdings (US) (JRSH) over the last 9 years, with Sep 2025 value amounting to $462,088.

  • Jerash Holdings (US)'s EBITDA fell 31.25% to $462,088 in Q3 2025 from the same period last year, while for Sep 2025 it was $599,642, marking a year-over-year increase of 115.75%. This contributed to the annual value of -$869,172 for FY2025, which is 63.95% up from last year.
  • As of Q3 2025, Jerash Holdings (US)'s EBITDA stood at $462,088, which was up 38.68% from $333,194 recorded in Q2 2025.
  • Jerash Holdings (US)'s EBITDA's 5-year high stood at $4.4 million during Q3 2021, with a 5-year trough of -$3.5 million in Q1 2024.
  • Its 3-year average for EBITDA is -$403,114, with a median of $309,103 in 2023.
  • As far as peak fluctuations go, Jerash Holdings (US)'s EBITDA spiked by 1,445.74% in 2021, and later tumbled by 1,659.53% in 2023.
  • Quarterly analysis of 5 years shows Jerash Holdings (US)'s EBITDA stood at $1.7 million in 2021, then plummeted by 45.92% to $928,622 in 2022, then tumbled by 64.32% to $331,341 in 2023, then slumped by 144.30% to -$146,775 in 2024, then slumped by 31.25% to $462,088 in 2025.
  • Its EBITDA stands at $462,088 for Q3 2025, versus $333,194 for Q2 2025 and -$48,865 for Q1 2025.